Omeros (OMER) Receivables - Other (2011 - 2026)
Omeros (OMER) posted Receivables - Other of $92000.0 for Q1 2026, down 87.73% sequentially from $750000.0 in Q4 2025, and down 93.65% YoY from $1.4 million in Q1 2025.
Powered by 
Analysis
Omeros (OMER) Receivables - Other (2011 - 2026) Analysis & Trends
Omeros has reported Receivables - Other for 16 years, with the latest figure at $92000.0 in Q1 2026.
- Quarterly Receivables - Other fell 93.65% year-over-year to $92000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $92000.0 (down 93.65% YoY) and the FY2025 annual result came in at $750000.0, down 6.13% from the prior year.
- Receivables - Other retreated to $92000.0 in Q1 2026 per OMER's latest filing, from $750000.0 in the prior quarter.
- Over five years, Receivables - Other peaked at $1.4 million in Q1 2025 and troughed at $92000.0 in Q1 2026.
- A 5-year average of $675235.3 and a median of $741000.0 in 2022 frame the typical range for Receivables - Other.
- The sharpest annual moves came in 2024 and 2026: Receivables - Other soared 927.42% in 2024, then sank 93.65% in 2026.
- Over 5 years, Receivables - Other stood at $255000.0 in 2022, then jumped by 438.04% to $1.4 million in 2023, then tumbled by 41.76% to $799000.0 in 2024, then fell by 6.13% to $750000.0 in 2025, then slumped by 87.73% to $92000.0 in 2026.
- According to Business Quant data, Receivables - Other over the past three periods registered $92000.0, $750000.0, and $863000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn |
| 10 | Omeros | 1.38 Bn | 1.38 Bn | 27.73 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 111,000.00 |
| Mar 31, 2026 | 92,000.00 |
| Dec 31, 2025 | 750,000.00 |
| Sep 30, 2025 | 863,000.00 |
| Jun 30, 2025 | 1.07 Mn |
| Mar 31, 2025 | 1.45 Mn |
| Dec 31, 2024 | 799,000.00 |
| Sep 30, 2024 | 299,000.00 |
| Jun 30, 2024 | 1.27 Mn |
| Mar 31, 2024 | 656,000.00 |
| Dec 31, 2023 | 1.37 Mn |
| Sep 30, 2023 | 220,000.00 |
| Jun 30, 2023 | 124,000.00 |
| Mar 31, 2023 | 302,000.00 |
| Dec 31, 2022 | 255,000.00 |
| Sep 30, 2022 | 741,000.00 |
| Jun 30, 2022 | 810,000.00 |
| Mar 31, 2022 | 408,000.00 |
| Dec 31, 2021 | 1.65 Mn |
| Sep 30, 2021 | 274,000.00 |